Company news
Cambridge Nutritional Sciences Plc (LSE:CNSL) news
Every Cambridge Nutritional Sciences Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Updated Notice of Results & Investor Presentation
August 17, 2026
Trading & Business Update
April 22, 2026
Director/PDMR Shareholding
November 19, 2025
Half-year Report
November 10, 2025
Notice of Results & Investor Presentation
November 4, 2025
Result of AGM
September 25, 2025
Notice of AGM & Annual Report
August 28, 2025
Grant of Options
August 21, 2025
Final Results
August 19, 2025
Directorate Change
July 10, 2025
Holding(s) in Company
July 2, 2025
Trading Update
May 27, 2025
Resolution on HSE Matter
May 23, 2025
Appointment of Chief Executive Officer
April 1, 2025
Omega Diagnostics Summons Update
March 19, 2025
Omega Diagnostics court summons
January 21, 2025
Settlement of DHSC Claim
January 16, 2025
Notice of Results and Investor Presentation
November 15, 2024
Posting of Annual Report and Notice of AGM
August 15, 2024
Notice of Results
July 10, 2024
Trading Update and Directorate Change
April 22, 2024
Q2 2024 Industry Events Schedule
April 3, 2024
Issue of Equity and Total Voting Rights
January 30, 2024
Appointment of Operations Director
January 29, 2024
Scientific Educational Webinar and Industry Event
January 22, 2024
Scientific Educational Programme expanded
December 4, 2023
Warrant Expiry and Block Admission Cancellation
November 10, 2023
Change of website
September 15, 2023
Change of Name
September 15, 2023
AGM Statement
September 6, 2023
Update on proposed Share Reorganisation
September 1, 2023
Proposed Share Reorganisation Timetable
August 31, 2023
Board Appointment
August 17, 2023
Posting of Annual Report and confirmation of AGM
August 14, 2023
BLOCK LISTING SIX MONTHLY RETURN
May 10, 2023
Block Listing Six Monthly Return
March 22, 2023
Trading update
January 18, 2023
US expansion update
January 6, 2023
Second Price Monitoring Extn
December 13, 2022
Price Monitoring Extension
December 13, 2022
Receipt of deferred consideration
November 25, 2022
Confirmation of Results and Investor Presentation
November 15, 2022
Partnership agreement with Software Provider
November 14, 2022
Launch of new all-employee share incentive plan
November 8, 2022
AGM Statement and Notice of Results
October 26, 2022
Scientific Director to present at FIDHC
October 11, 2022
Positive WHO data received for VISITECT® CD4 test
October 5, 2022
Purchase of Shares by Directors
September 16, 2022
Investor presentation and Confirmation of AGM
September 13, 2022
Change of preliminary results date
August 31, 2022